Cargando…
Ulinastatin attenuates lipopolysaccharide-induced cardiac dysfunction by inhibiting inflammation and regulating autophagy
Ulinastatin exerts protective effects against lipopolysaccharide (LPS)-induced cardiac dysfunction. Autophagy has been demonstrated to serve an important role in sepsis-induced cardiomyopathy; however, whether ulinastatin has an anti-autophagic effect in sepsis requires further investigation. The pr...
Autores principales: | Zhao, Pin, Zhang, Li, Gao, Longfei, Ding, Qian, Yang, Qian, Kuai, Jianke |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7388552/ https://www.ncbi.nlm.nih.gov/pubmed/32765659 http://dx.doi.org/10.3892/etm.2020.8755 |
Ejemplares similares
-
Ulinastatin attenuates diabetes-induced cardiac dysfunction by the inhibition of inflammation and apoptosis
por: Wang, Wen-Ke, et al.
Publicado: (2017) -
Ulinastatin Reduces the Resistance of Liver Cancer Cells to Epirubicin by Inhibiting Autophagy
por: Song, Bin, et al.
Publicado: (2015) -
Ulinastatin post-treatment attenuates lipopolysaccharide-induced acute lung injury in rats and human alveolar epithelial cells
por: Luo, Yunpeng, et al.
Publicado: (2017) -
Inhibition of miRNA-1-Mediated Inflammation and Autophagy by Astragaloside IV Improves Lipopolysaccharide-Induced Cardiac Dysfunction in Rats
por: Wang, Qiuning, et al.
Publicado: (2022) -
Multi-organ protection of ulinastatin in traumatic cardiac arrest model
por: Liu, Shaoyun, et al.
Publicado: (2018)